How many insider trades does FilingIQ track for ETRA?

FilingIQ tracks 16 Form 4 insider transactions for ETRA (Electra Therapeutics, Inc.), covering filings from Sep 21, 2026 onwards. 16 of those are dated within the last 90 days.

Are ETRA insiders net buyers or net sellers?

Across the full Form 4 history for ETRA, 4 transactions (25%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does ETRA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.

What sector is ETRA in?

Electra Therapeutics, Inc. (ETRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $710.52M.

ETRA insider trading

NasdaqGS Healthcare

Electra Therapeutics, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades

Last 90 days

Buys / sells

25% / 0%

Market cap

$710.52M

About Electra Therapeutics, Inc.

Electra Therapeutics, Inc. is a clinical-stage biotechnology company. It develops therapies that target signal regulatory proteins for the treatment of novel targets for diseases in immunology and cancer. Its product, ELA026, is a monoclonal antibody that targets signal regulatory protein on the cell surface of myeloid and T cells and depletes pathological immune cells, enabling medical professionals to find an approved treatment for secondary hemophagocytic lymphohistiocytosis, a life-threatening hyperinflammatory condition. The company was incorporated in 2018 and is based in South San Francisco, California.

Company website: electra-therapeutics.com

ETRA insider activity at a glance

FilingIQ tracks 16 insider transactions for ETRA in filings since Sep 21, 2026. The most recent transaction is dated Sep 21, 2026.

Across the full history, 4 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.

View live ETRA trades on FilingIQ Raw filings on SEC EDGAR

Latest ETRA Form 4 filings

Parry Graham Chief Scientific Officer

C Sep 21, 2026

Koe Gary S. Chief Technical Officer

C Sep 21, 2026

Dong Quehuong (Kathy) President & CEO

C Sep 21, 2026

Stagliano Nancy

C Sep 21, 2026

Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.

Other Healthcare tickers with recent insider activity

UTHR 865

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

ATTO 123

Attovia Therapeutics, Inc.

TEM 104

Tempus AI, Inc.

CORT 103

CORCEPT THERAPEUTICS INC

CSTL 100

CASTLE BIOSCIENCES INC

Frequently asked

How many insider trades does FilingIQ track for ETRA?: FilingIQ tracks 16 Form 4 insider transactions for ETRA (Electra Therapeutics, Inc.), covering filings from Sep 21, 2026 onwards. 16 of those are dated within the last 90 days.
Are ETRA insiders net buyers or net sellers?: Across the full Form 4 history for ETRA, 4 transactions (25%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ETRA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
What sector is ETRA in?: Electra Therapeutics, Inc. (ETRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $710.52M.

Methodology & sources

Every ETRA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.